GSA Capital Partners’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-52,850
Closed -$960K 1784
2024
Q3
$960K Buy
+52,850
New +$960K 0.07% 492
2023
Q3
Sell
-9,799
Closed -$403K 1676
2023
Q2
$403K Buy
+9,799
New +$403K 0.04% 875
2022
Q3
Sell
-11,151
Closed -$602K 1681
2022
Q2
$602K Buy
+11,151
New +$602K 0.09% 381
2021
Q3
Sell
-22,148
Closed -$1.51M 1586
2021
Q2
$1.51M Buy
+22,148
New +$1.51M 0.17% 117
2021
Q1
Sell
-6,368
Closed -$413K 1268
2020
Q4
$413K Buy
6,368
+317
+5% +$20.6K 0.07% 544
2020
Q3
$286K Buy
+6,051
New +$286K 0.05% 769
2020
Q1
Sell
-5,079
Closed -$296K 1274
2019
Q4
$296K Sell
5,079
-13,305
-72% -$775K 0.03% 1037
2019
Q3
$1.1M Buy
18,384
+2,984
+19% +$179K 0.15% 125
2019
Q2
$860K Buy
15,400
+1,108
+8% +$61.9K 0.1% 310
2019
Q1
$796K Buy
+14,292
New +$796K 0.08% 411
2018
Q3
Sell
-8,355
Closed -$538K 1748
2018
Q2
$538K Buy
+8,355
New +$538K 0.03% 1120
2017
Q4
Sell
-28,249
Closed -$1.43M 1668
2017
Q3
$1.43M Buy
28,249
+19,226
+213% +$971K 0.1% 305
2017
Q2
$492K Sell
9,023
-42,283
-82% -$2.31M 0.03% 1013
2017
Q1
$2.16M Buy
51,306
+46,090
+884% +$1.94M 0.12% 226
2016
Q4
$224K Sell
5,216
-148
-3% -$6.36K 0.01% 1523
2016
Q3
$221K Sell
5,364
-15,718
-75% -$648K 0.01% 1548
2016
Q2
$841K Buy
21,082
+4,278
+25% +$171K 0.05% 743
2016
Q1
$566K Sell
16,804
-51,440
-75% -$1.73M 0.04% 929
2015
Q4
$2.31M Buy
68,244
+42,040
+160% +$1.42M 0.11% 205
2015
Q3
$780K Buy
26,204
+6,383
+32% +$190K 0.04% 840
2015
Q2
$546K Sell
19,821
-3,181
-14% -$87.6K 0.02% 1301
2015
Q1
$580K Buy
23,002
+11,499
+100% +$290K 0.02% 1278
2014
Q4
$255K Buy
+11,503
New +$255K 0.02% 1355
2014
Q1
Sell
-15,662
Closed -$305K 1661
2013
Q4
$305K Sell
15,662
-734
-4% -$14.3K 0.02% 1184
2013
Q3
$270K Buy
+16,396
New +$270K 0.02% 1215